Literature DB >> 34918532

Biomarkers of the Physical Function Mobility Domains Among Patients Hospitalized in Internal Medicine.

P Vrbová1, S Valášková, A Gažová, J Smaha, M Kužma, J Kyselovič, J Payer, T Koller.   

Abstract

Hospitalized patients in internal medicine have an increased risk of low physical reserve which further declines during the hospital stay. The diagnosis requires bed-side testing of functional domains or more complex investigations of the muscle mass. Clinically useful biomarkers of functional status are needed, thus we aimed to explore the potential of microRNAs. Among hospitalized patients, we recorded the basic demographics, anthropometrics, nutritional status, and physical function domains: hand-grip strength (HGS, abnormal values M<30 kg, W<20 kg), balance (<30 s), chair-stands speed (CHSS<0.5/s) and gait speed (GS<0.8 m/s). A panel of five micro-RNAs (miRNA 1, miRNA 133a, miRNA 133b, miRNA 29a, miRNA 29b) and basic blood biochemistry and vitamin D values were recorded. We enrolled 80 patients (M40, W40), with a mean age of 68.8±8.4 years. Obesity was observed in 27.5 % and 30 %, low HGS and low CHSS in 65.0, 77.5 %, and 80, 90 % of men and women respectively. The median hospital stay was 6.5 days. MiRNA29a and miRNA29b have the strongest correlation with the triceps skinfold (miRNA 29b, r=0.377, p=0.0006) and CHSS (miRNA 29a, r=0.262, p=0.02). MiRNA 29a, miRNA 29b and 133a levels were significantly higher in patients with CHSS<0.5/s. Other anthropometric parameters, mobility domains, or vitamin D did not correlate. All miRNAs except of miRNA 1, could predict low CHSS (miRNA29b, AUROC=0.736 CI 0.56-0.91, p=0.01), particularly in patients with low HGS (miRNA 29b, AUROC=0.928 CI 0.83-0.98). Among hospitalized patients in internal medicine, low functional status was frequent. MicroRNAs were fair biomarkers of the antigravity domain, but not other domains. Larger studies with clinical endpoints are needed.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34918532      PMCID: PMC8884383          DOI: 10.33549/physiolres.934777

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  24 in total

Review 1.  microRNAs: Modulators of the underlying pathophysiology of sarcopenia?

Authors:  David M Brown; Katarzyna Goljanek-Whysall
Journal:  Ageing Res Rev       Date:  2015-09-02       Impact factor: 10.895

Review 2.  Prevalence of frailty in community-dwelling older persons: a systematic review.

Authors:  Rose M Collard; Han Boter; Robert A Schoevers; Richard C Oude Voshaar
Journal:  J Am Geriatr Soc       Date:  2012-08-06       Impact factor: 5.562

Review 3.  Evidence on Physical Activity and the Prevention of Frailty and Sarcopenia Among Older People: A Systematic Review to Inform the World Health Organization Physical Activity Guidelines.

Authors:  Juliana S Oliveira; Marina B Pinheiro; Nicola Fairhall; Sarah Walsh; Tristan Chesterfield Franks; Wing Kwok; Adrian Bauman; Catherine Sherrington
Journal:  J Phys Act Health       Date:  2020-08-11

4.  Identifying Exosome-Derived MicroRNAs as Candidate Biomarkers of Frailty.

Authors:  B R Ipson; M B Fletcher; S E Espinoza; A L Fisher
Journal:  J Frailty Aging       Date:  2018

5.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

6.  Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; L Woodhouse; L Rodríguez-Mañas; L P Fried; J Woo; I Aprahamian; A Sanford; J Lundy; F Landi; J Beilby; F C Martin; J M Bauer; L Ferrucci; R A Merchant; B Dong; H Arai; E O Hoogendijk; C W Won; A Abbatecola; T Cederholm; T Strandberg; L M Gutiérrez Robledo; L Flicker; S Bhasin; M Aubertin-Leheudre; H A Bischoff-Ferrari; J M Guralnik; J Muscedere; M Pahor; J Ruiz; A M Negm; J Y Reginster; D L Waters; B Vellas
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

7.  Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults.

Authors:  Huang-Chun Liu; Der-Sheng Han; Chih-Chin Hsu; Jong-Shyan Wang
Journal:  BMC Geriatr       Date:  2021-01-30       Impact factor: 3.921

8.  MicroRNAs in Sarcopenia: A Systematic Review.

Authors:  Katsunori Yanai; Shohei Kaneko; Hiroki Ishii; Akinori Aomatsu; Kiyonori Ito; Keiji Hirai; Susumu Ookawara; Kenichi Ishibashi; Yoshiyuki Morishita
Journal:  Front Med (Lausanne)       Date:  2020-05-28

9.  Expression Patterns of Muscle-Specific miR-133b and miR-206 Correlate with Nutritional Status and Sarcopenia.

Authors:  Francesca Iannone; Alberto Montesanto; Erika Cione; Paolina Crocco; Maria Cristina Caroleo; Serena Dato; Giuseppina Rose; Giuseppe Passarino
Journal:  Nutrients       Date:  2020-01-22       Impact factor: 5.717

10.  Circulating MicroRNAs in Plasma Decrease in Response to Sarcopenia in the Elderly.

Authors:  Nana He; Yue Lin Zhang; Yue Zhang; Beili Feng; Zaixing Zheng; Dongjuan Wang; Shun Zhang; Qi Guo; Honghua Ye
Journal:  Front Genet       Date:  2020-03-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.